Submitted by Anonymous (not verified) on 10 December 2025 - 13:32
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 13, Status: Authorised